AHK-Cu

Unreconstituted (lyophilized) AHK-Cu is generally stable for extended periods when kept refrigerated (2–8°C) and can last significantly longer if kept frozen. Once reconstituted, solutions are more sensitive and should be refrigerated and used within a limited window (commonly cited as up to a few weeks), since copper-peptide complexes can degrade with heat, light, or pH shifts. Avoid repeated freeze-thaw cycles and check your specific vendor's documentation for exact stability guidance.

In preclinical and in-vitro studies, AHK-Cu has been investigated for its ability to stimulate dermal papilla cells and extend the hair growth cycle, support fibroblast activity and collagen synthesis, and promote angiogenesis (new blood vessel formation) via VEGF signaling. Most of this evidence comes from lab and tissue-culture studies rather than large-scale human clinical trials, so findings should be considered preliminary and research-stage.

As a peptide sold for research use only, AHK-Cu has not been evaluated by the FDA for safety or efficacy in humans, and comprehensive human safety data is limited. Potential concerns raised in the peptide research community include local irritation at injection or application sites and general risks associated with unregulated, non-clinical-grade compounds. Anyone considering use should consult a qualified healthcare professional and treat the product as intended: for laboratory research, not human consumption.

AHK-Cu is legal to purchase in most jurisdictions when sold and labeled explicitly for research use only, similar to other research peptides. It is not approved by the FDA or equivalent regulatory bodies for medical, therapeutic, or cosmetic use in humans. Buyers are responsible for understanding and complying with their local laws regarding research chemical purchases.

Reputable research peptide vendors typically publish third-party testing (such as HPLC or mass spectrometry) confirming purity, commonly ≥98–99%, along with a certificate of analysis (CoA) for each batch. When comparing vendors, prioritize those that provide accessible lab testing documentation, clear reconstitution instructions, and transparent sourcing over price alone, since purity and handling directly affect research reliability.

AHK-Cu is sometimes referenced alongside related copper peptides like GHK-Cu in research contexts exploring skin and hair follicle biology, since both are copper-binding tripeptide/tetrapeptide analogs with overlapping areas of study. There is limited published research specifically evaluating combined protocols, so any stacking approach should be based on documented research methodology rather than assumption. As with all research peptides, combination use should only be considered in a controlled research context.